Since its inception in 1980, the Sidney Kimmel Comprehensive Cancer Center (SKCCC) Flow Cytometry Shared Resource has continuously offered state-of-the art cell sorting and analysis capabilities to the members of the SKCCC. These services are provided in a timely, flexible and affordable manner to Cancer Center members from across the entire medical campus. The resources provided by the Flow Core are not a duplication of those available elsewhere, and range from basic two color analyses, to complex sorting experiments involving up to 14 colors and 16 discrete parameters. Since the last renewal, the Flow Core has undergone the most dramatic update in its history. Specifically, the Core has acquired several new instruments, including two new high-end sorters. Both of these are high-speed, 14 color / 16 parameter Facs Aria units. The second unit is housed in a custom BSL-3 BioPROtect 111 Bio-Containment Enclosure, permitting users to sort un-fixed human cells under applicable CDC guidelines. The Core has also been relocated to a new, custom-designed physical space, a 1400 square ft. suite of three rooms on the fourth floor of the SKCCC Cancer Research Building (CRBI). Also, a new analysis unit, a special order research platform (SORP) LSR-II, with enhanced flow rates and detection capabilities has been added. Perhaps most significantly, two new experienced and dedicated personnel have been hired. Ms. Ada Tam serves as the Resource Manager;and Mr. Richard (Lee) Blosser who serves as co-manager and training Director. Their respective roles will be further detailed below. However, it should be noted that the Core now has the resources to provide training on each of the analysis units, cell sorting services, as well as back-end analysis assistance. Lay: Flow cytometry, is a method of sorting and measuring types of cells by fluorescent labeling of markers on the surface of the cells. It is sometimes referred to as FACS (Fluorescent Activated Cell Sorting) analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-51
Application #
8661008
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
51
Fiscal Year
2014
Total Cost
$173,195
Indirect Cost
$66,501
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Zeidner, Joshua F; Zahurak, Marianna; Rosner, Gary L et al. (2015) The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? Leuk Lymphoma 56:128-34
Penet, Marie-France; Shah, Tariq; Bharti, Santosh et al. (2015) Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism. Clin Cancer Res 21:386-95
Sharabi, Andrew B; Nirschl, Christopher J; Kochel, Christina M et al. (2015) Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer Immunol Res 3:345-55
Peltonen, Karita; Colis, Laureen; Liu, Hester et al. (2014) A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell 25:77-90
DeZern, Amy E; Guinan, Eva C (2014) Aplastic anemia in adolescents and young adults. Acta Haematol 132:331-9
Paller, Channing J; Wissing, Michel D; Mendonca, Janet et al. (2014) Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer. Cancer Med 3:1322-35
Maldonado, Leonel; Teague, Jessica E; Morrow, Matthew P et al. (2014) Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci Transl Med 6:221ra13
Schweizer, Michael T; Antonarakis, Emmanuel S (2014) Chemotherapy and its evolving role in the management of advanced prostate cancer. Asian J Androl 16:334-40
Huang, Peng; Ou, Ai-hua; Piantadosi, Steven et al. (2014) Formulating appropriate statistical hypotheses for treatment comparison in clinical trial design and analysis. Contemp Clin Trials 39:294-302
Bhatnagar, Akrita; Wang, Yuchuan; Mease, Ronnie C et al. (2014) AEG-1 promoter-mediated imaging of prostate cancer. Cancer Res 74:5772-81

Showing the most recent 10 out of 357 publications